A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of ALG-097558 in Subjects With Hepatic Impairment and in Healthy Subjects With Normal Hepatic Function
Clinical trial NCT06568861 · COMPLETED
Trial details
- NCT number
- NCT06568861
- Sponsor
- Aligos Therapeutics
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-01-13
- Primary completion
- 2025-07-16
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.